Symptom-centric view
Product use issue
Substances reporting Product use issue disproportionately — ranked by ROR.
showing 4 of 4
| Substance ↓ | ROR [95% CI] | Reports | Category | Label |
|---|---|---|---|---|
tretinoin Retin-A · Atralin | 4.2 [3.8–4.7] | 312 | injectables | new |
minoxidil Rogaine · Loniten | 2.2 [2.1–2.4] | 865 | glp-1 | new |
| 5.6 [5.5–5.7] | 6,281 | algemeen | new | |
| 3.7 [3.4–4.0] | 499 | algemeen | new |
ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).